Oric Pharmaceuticals, Inc. ORIC Accrued Liabilities, Current
Accrued Liabilities, Current at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oric Pharmaceuticals, Inc.'s accrued liabilities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oric Pharmaceuticals, Inc.'s accrued liabilities, current?
- Oric Pharmaceuticals, Inc. (ORIC) reported accrued liabilities, current of $14.88M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s accrued liabilities, current changed year-over-year?
- Oric Pharmaceuticals, Inc.'s accrued liabilities, current increased by 19.4% year-over-year, from $12.46M to $14.88M.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s accrued liabilities, current?
- Over 5 years (2020 to 2025), Oric Pharmaceuticals, Inc.'s accrued liabilities, current has grown at a 15.0% compound annual growth rate (CAGR), from $8.25M to $16.59M.